Image de couverture de livre

Science Behind Alzheimer's Treatments: A Comprehensive Yet Simplified Exploration

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Cancel Asencio, Héctor
Format:	Recurso digital
Langue:	anglais
Publié:	Zenodo 2024
Sujets:	Alzheimer Disease
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer’s Diseases
par: Kassim Adebambo, et autres
Publié: (2024)

Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer’s Disease
par: Samat Kozhakhmetov, et autres
Publié: (2024)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
par: Nicholas R. Ray, et autres
Publié: (2024)

Navigating late‐stage dementia: A perspective from the Alzheimer's Association
par: Kristen Clifford, et autres
Publié: (2024)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
par: María A. Rodríguez‐Santiago, et autres
Publié: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
par: Juliana N. Souza‐Talarico, et autres
Publié: (2025)

Diagnostic performance of light reflex pupillometry in Alzheimer's disease
par: Mathias Holsey Gramkow, et autres
Publié: (2024)

Association between BrainAGE and Alzheimer's disease biomarkers
par: Yousaf Abughofah, et autres
Publié: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
par: Thomas Claessen, et autres
Publié: (2025)

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
par: Diana Esteller‐Gauxax, et autres
Publié: (2026)

Treating Alzheimer's disease in a person living with HIV
par: David B. Clifford, et autres
Publié: (2026)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
par: Samantha C. Burnham, et autres
Publié: (2026)

The family caregiver’s discourse on the hospitalization of the elderly with Alzheimer’s disease
par: Gabriela Pizelli Mocco Grillo
Publié: (2017)

A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
par: Sara Teijeira‐Portas, et autres
Publié: (2026)

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
par: Peter Thomas, et autres
Publié: (2024)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
par: David Foxe, et autres
Publié: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
par: Sofia Toniolo, et autres
Publié: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
par: Andrée‐Ann Baril, et autres
Publié: (2024)

Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
par: Manuela Dicarlo, et autres
Publié: (2026)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
par: Alisa Bannerjee, et autres
Publié: (2025)

A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions
par: Ananthan Ambikairajah, et autres
Publié: (2025)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
par: Katharina Bolsewig, et autres
Publié: (2024)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
par: Sebastiaan De Keersmaecker, et autres
Publié: (2024)

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
par: Fang Wang, et autres
Publié: (2025)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
par: John T. O'Brien
Publié: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
par: Darren M. Lipnicki, et autres
Publié: (2026)

Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
par: Bethany C. Curd, et autres
Publié: (2026)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
par: Ying Xia, et autres
Publié: (2025)

Machine learning models of Alzheimer's disease spectrum using blood tests
par: Nicola Walter Falasca, et autres
Publié: (2025)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
par: Willa D. Brenowitz, et autres
Publié: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
par: Soheil Mohammadi, et autres
Publié: (2025)

White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
par: Antoine Garnier‐Crussard, et autres
Publié: (2026)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
par: Steffi De Meyer, et autres
Publié: (2025)

The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
par: Julianne G. Clina, et autres
Publié: (2026)

Letter response to Clifford et al. “Navigating late‐stage dementia: A perspective from the Alzheimer's Association”
par: Stanley Arnold Terman, et autres
Publié: (2024)

Peripheral oxidative stress related biomarkers in Alzheimer's disease: A systematic review of their implications for diagnosis and disease monitoring
par: George Nkrumah Osei, et autres
Publié: (2026)

Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
par: Chloe Walsh, et autres
Publié: (2026)

Increased risk of infusion‐related reactions switching between monoclonal antibodies for Alzheimer's disease: A case series
par: Ganesh Gopalakrishna, et autres
Publié: (2026)

Assessing Alzheimer's disease via plasma extracellular vesicle–derived mRNA
par: Le Hoang Phu Pham, et autres
Publié: (2024)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
par: Hossein Moein Taghavi, et autres
Publié: (2024)